These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8164367)

  • 1. [Pharmacological mechanism of action and development of anti-steroid hormones].
    Oh-ishi S
    Nihon Rinsho; 1994 Mar; 52(3):679-84. PubMed ID: 8164367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of antisteroid hormones at the receptor level.
    Baulieu EE
    Kidney Int Suppl; 1988 Oct; 26():S2-7. PubMed ID: 3059030
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
    Nicholson RI; Walker KJ; Davies P
    Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778
    [No Abstract]   [Full Text] [Related]  

  • 6. Castration and antisteroid treatment impair vocal learning in male zebra finches.
    Bottjer SW; Hewer SJ
    J Neurobiol; 1992 Jun; 23(4):337-53. PubMed ID: 1634883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal therapy of prostate cancer.
    Labrie F
    Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonists, anti-progestins, anti-androgens, long-term-release GnRH agonists and anti-estrogens in canine reproduction: a review.
    Gobello C
    Theriogenology; 2006 Oct; 66(6-7):1560-7. PubMed ID: 16542717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors.
    McDonnell DP; Clemm DL; Imhof MO
    Semin Cancer Biol; 1994 Oct; 5(5):327-36. PubMed ID: 7849261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
    Jacobi GH; Wenderoth UK
    Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.
    Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M
    Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention.
    Jordan VC
    Cancer Res; 2009 Feb; 69(4):1243-54. PubMed ID: 19208829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormone agonists and antagonists in the treatment of cancer.
    Dreicer R; Wilding G
    Cancer Invest; 1992; 10(1):27-41. PubMed ID: 1370912
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action mechanism of sex steroid hormones].
    Kato J
    Nihon Rinsho; 1979 Jun; 37(6):1218-26. PubMed ID: 384049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid and peptide hormones and growth factors.
    Howell A; Wakeling AE
    Cancer Chemother Biol Response Modif; 1988; 10():117-28. PubMed ID: 3079380
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology and clinical use of sex steroid hormone receptor modulators.
    Cleve A; Fritzemeier KH; Haendler B; Heinrich N; Möller C; Schwede W; Wintermantel T
    Handb Exp Pharmacol; 2012; (214):543-87. PubMed ID: 23027466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone treatment of prostate carcinoma: past achievements and current perspectives].
    Debruyne FM
    Ned Tijdschr Geneeskd; 1986 Apr; 130(17):768-71. PubMed ID: 2423888
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma.
    Santen RJ; Manni A; Harvey H
    Breast Cancer Res Treat; 1986; 7(3):129-45. PubMed ID: 3096402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
    Schally AV; Redding TW; Comaru-Schally AM
    Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.